NIH #5P01CA275746-02
Core B: Molecular Pathology and Bioinformatics Core
Active
- Amount
- $698K
- Period
- 2024-09-03 → 2029-08-31
- PIs
- 1
- Est. capacity / PI
- ~7 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #1P01CA275746-01A1
Core B: Molecular Pathology and Bioinformatics Core
Active
- Amount
- $689K
- Period
- 2024-09-03 → 2029-08-31
- PIs
- 1
- Est. capacity / PI
- ~7 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R25CA233208-06
MSK Computational Biology Summer Program
Active
- Amount
- $288K
- Period
- 2019-07-01 → 2029-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #2R25CA233208-05
MSK Computational Biology Summer Program
Active
- Amount
- $320K
- Period
- 2019-07-01 → 2029-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA273224-04
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Active
- Amount
- $735K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA273224-03
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Active
- Amount
- $698K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA273224-02
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Active
- Amount
- $719K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #1R01CA273224-01
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Active
- Amount
- $734K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R44HD100243-06
IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis
Active
- Amount
- $827K
- Period
- 2020-07-02 → 2027-05-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at PLAKOUS THERAPEUTICS, INC.
NIH #5R25CA233208-03
MSK Computational Biology Summer Program
- Amount
- $220K
- Period
- 2019-07-01 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R25CA233208-02
MSK Computational Biology Summer Program
- Amount
- $220K
- Period
- 2019-07-01 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #1R25CA233208-01A1
MSK Computational Biology Summer Program
- Amount
- $230K
- Period
- 2019-07-01 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R25CA233208-04
MSK Computational Biology Summer Program
- Amount
- $220K
- Period
- 2019-07-01 → 2024-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA227534-05
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing
- Amount
- $698K
- Period
- 2019-04-01 → 2024-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA227534-04
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing
- Amount
- $698K
- Period
- 2019-04-01 → 2024-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA227534-03
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing
- Amount
- $712K
- Period
- 2019-04-01 → 2024-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R01CA227534-02
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing
- Amount
- $712K
- Period
- 2019-04-01 → 2024-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #1R01CA227534-01A1
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing
- Amount
- $727K
- Period
- 2019-04-01 → 2024-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH